Exagen Inc. (XGN) Tops Q4 EPS by 12c

Exagen Inc. (NASDAQ: XGN) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.66 million versus the consensus estimate of $14.17 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Criteo Is Said To Attract Vista Equity-backed Takeover Offer - Bloomberg
• Active options: SOFI PLTR AMD IREN GOOGL AVGO MSTR WULF NFLX BMNR HOOD
• Freedom Broker Starts Niagen Bioscience (NAGE) at Buy